Welcome to the e-CCO Library!

N02: PREVIEW study: Factors associated with willingness to switch from intravenous to subcutaneous formulations of CT-P13 and vedolizumab in patients with Inflammatory Bowel Disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Asnong, K.(1);Hoefkens, E.(1);Lembrechts, N.(1);Van de Schoot, I.(1);Pouillon, L.(1);Bossuyt, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
N02: Supporting psychosocial and emotional well-being and building resilience in family members of people with IBD: RCT feasibility and acceptability study
Year: 2025
Source: ECCO'25
Authors: Thapwongx7x7x7 P.(1)*;Nortonx7x7x7 C.(1);Rowlandx7x7x7 E.(1);Czuber-Dochanx7x7x7 W.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
N02: The importance of the multidisciplinary team (MDT) and its impact on quality of life and medication adherence in patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Herrerias, G.(1);Barros, J.R.(2);Lopes, M.A.(1);Saad-Hossne, R.(3);Baima, J.P.(4);Sassaki, L.Y.(4);
Created: Friday, 11 February 2022, 3:52 PM
N03 Disease burden of patients with inflammatory bowel disease from the viewpoint of QOL and depression
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Takahashi1, N. Aoyama2, M. Nunotani3

Created: Thursday, 30 January 2020, 10:12 AM
N03 Please refer to N03 in the chapter for ‘Nurses poster presentations’
Year: 2020
Source:

ECCO'20 Vienna

Created: Thursday, 30 January 2020, 10:12 AM
N030: Real benefits of IBD nurse-led clinics: Improving awareness and uptake of the HPV vaccine in IBD patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Keogh*, M. Burke

Created: Thursday, 21 February 2019, 9:14 AM
N031: The effect of web-based education on disease activity, symptom management, and quality of life on patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

B.N. Ozgursoy Uran1,2*, Y. Yildirim3, F. Senuzun Aykar3, B. Unsal1

Created: Thursday, 21 February 2019, 9:14 AM
N032: Impact of pain due to subcutaneous administration of a biological drug
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Gely1, L. Marin2, J. Gordillo1*, M. Mañosa2,3, F. Bertoletti1, F. Cañete2, C. Gonzalez-Muñosa1, E. Cabré2,3, E. Domènech2,3, E. Garcia-Planella1

Created: Thursday, 21 February 2019, 9:14 AM
N033: Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Fourie1,2*, D. Jackson1, H. Aveyard1, A. Simmons2

Created: Thursday, 21 February 2019, 9:14 AM
N034: Patient satisfaction with brand changes of Mesalazine medications in four hospitals in the North West of England
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Campbell1*, E. Nelson2, J. Hocking3, J. Hodgins4, T. Hickey3, V. Geraghty5

Created: Thursday, 21 February 2019, 9:14 AM
N035: The use of intravenous (IV) ferric carboxymaltose in a paediatric IBD population
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Crook*, T. Tyrrell, W. Hyer

Created: Thursday, 21 February 2019, 9:14 AM
N036: The advanced nursing care in IBD: Study on biosimilar drugs
Year: 2018
Source: ECCO '18 Vienna
Authors:

F.M. Onidi*, S. Simbula, V. Vacca, L. Binaghi, M. Pellecchia, F. Cabras, M. Demurtas, G. Mocci

Created: Thursday, 21 February 2019, 9:14 AM
N037: Attitudes of Crohn’s disease patients toward self-monitoring trough an App
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.C. Morete Pérez*, V. Ollero, R. Fraga, A. Lopez, A. Echarri

Created: Thursday, 21 February 2019, 9:14 AM
N03: Can post biologic infusion monitoring be reduced? A mulit-centred retrospective study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Younge1, L. Whitley2, S. Azana3, L. Younge*4

Created: Friday, 22 February 2019, 9:41 AM
N03: Information flow experiences during COVID-19 in IBD patients: a prospective observational study
Year: 2021
Source: ECCO'21 Virtual
Authors: Geens, P.(1);De Dycker, E.(1);Paps, A.(1);Lambrechts, T.(1);Sabino, J.(1);Ferrante, M.(1);Vermeire, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
N03: Introducing video consultations as part of an IBD tight monitoring care pathway: interim results of the INTERACTION project
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hoefkens, E.(1)*;Lembrechts, N.(1);Bossuyt, P.(1);Pouillon, L.(1);
Created: Friday, 14 July 2023, 10:43 AM
N03: Medication adherence in relation to Health-related Quality of Life in patients with Inflammatory Bowel Disease – a cross-sectional study
Year: 2022
Source: ECCO'22
Authors: Johansson, E.(1);Lovén WickmanRN- PhD, U.(2);
Created: Friday, 11 February 2022, 3:52 PM
N03: The impact of IBD on sexual health: a gender-based cross-sectional comparison with a non-IBD population
Year: 2025
Source: ECCO'25
Authors: Pérez Martínezx7x7x7 Z.(1)*;Ollerx7x7x7 E.(1);L Hamiltonx7x7x7 A.(2);Herrera de Guisex7x7x7 C.(1);Mayorgax7x7x7 L.(1);Céspedesx7x7x7 E.(1);Serrax7x7x7 X.(1);Lastirix7x7x7 E.(1);Zuriguelx7x7x7 E.(3);Roblesx7x7x7 V.(1);Borruelx7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
N04: A systematic review of the impact of Inflammatory Bowel Disease (IBD) on family members
Year: 2022
Source: ECCO'22
Authors: Thapwong, P.(1);Norton, C.(1);Rowland, E.(1);Farah, N.(1); Czuber- Dochan, W.(1);
Created: Friday, 11 February 2022, 3:52 PM